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The administration of contrast medium to increase the diagnostic accuracy of computed tomography is usual. However, contrast material has the risk of 
renal toxicity (1,2). Contrast-induced nephropathy firstly 
detected in 1950, in a group of patients with underlying 
kidney disease who underwent coronary angiography. 
Since that time, it is considered as a nephrotoxin, while 
numerous amount of interventions and literature has 
devoted to this issue. In fact, post-contrast acute kidney 
injury is one of the furthermost common causes of 
acute renal failure (1). Various mechanisms like direct 
toxicity of contrast agents to the tubular epithelial cells, 
running to apoptosis and necrosis of epithelial cells and 
finally dysfunction of tubules. Accordingly, an indirect 
mechanism of contrast-induced nephropathy is vasomotor 
alteration in kidney due to vasoactive substances like 
endothelin, nitric oxide and prostaglandins, which 
leads to ischemic injury (3-5). Then ischemic injury 
directs to intra-renal vasoconstriction and diminution 
of glomerular blood flow. Diminution of glomerular 
blood flow attributed to the release of reactive oxygen 
species and consequently ischemia of the outer part of 
the medulla, furthermore deteriorating renal tubular 
cell damage. Contrast-induced nephropathy has been 
detected to be related to the poor clinical consequences, 
comprising augmented lengthened duration of hospital 
admission, the necessity for renal replacement therapy 
and an increase in major adverse cardiac events, and also 
increase of morbidity and mortality (1,6,7). However, 
the risk of acute renal failure after the use of contrast 
agents is also predisposed by patients’ condition and the 
type of procedure. Therefore, prompt recognition of the 
risk factors to eradicate the potentially avoidable acute 
kidney injury after contrast medium administration is a 
serious healthcare issue. Pre-existing chronic renal failure, 
high osmolality agents, diabetes mellitus, hemodynamic 
instability, high volume of contrast agent and intra-
arterial iodine administration are the risk factors for 
contrast-induced nephropathy. In critically ill individuals 
with acute kidney injury, it is difficult to discriminate the 
role of contrast medium and other probable factors to the 
extension of acute kidney injury, since some additional 
factors like inflammation, hypotension, infection, and 
other nephrotoxic substances may aggravate the condition 
(8-10). In a report by Weisbord et al, no advantage 
of intravenous sodium bicarbonate above intravenous 
sodium chloride or of oral acetylcysteine above placebo 
for the prevention of death, the need for dialysis, or 
permanent deterioration in renal function at 90 days or 
the prevention of contrast-induced nephropathy was seen. 
In this study unlike most previous trials their primary 
end-point was not the most broadly accepted definition 
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of contrast-associated acute kidney injury (increase in 
serum creatinine 25% or at least 0.5 mg/dL from baseline 
at 3 to 5 days after angiography) (11). In our mind, 
consideration on this new end point is logical. In a recent 
study by Nijssen et al, no prophylaxis to be non-inferior 
and cost-saving in stopping contrast-associated renal 
injury compared with intravenous hydration regarding the 
present clinical practice guidelines was mentioned (12). 
More recently, Mehran et al highlighted an important 
insight toward contrast-associated acute kidney injury 
as a marker of increased risk of chronic kidney disease 
and long-term death. A small and transient elevation in 
the plasma creatinine should be considered as a marker 
of poor outcomes rather than a mediator of the outcome 
(13). In fact, kidney with its high energy requirements 
and complex microvascular network is particularly 
susceptible to contrast-associated acute kidney injury 
including vasoconstriction, tubule toxicity, medullary 
hypoxia, and reactive oxygen species injury. Preventive 
consideration of sodium bicarbonate, oral acetyl cysteine 
and hydration are hypothetically toward those underlying 
mechanism (1,14). We can consider contrast-associated 
acute kidney injury as a stress test that reveals an existing 
generalized micro-vascular abnormality. We can compare 
the contrast-associated acute kidney injury with cardiac 
stress test that reveals an existing underlying cardiac 
abnormality, since most of the early creatinine elevation 
returns to normal. However, underlying pathophysiologic 
mechanisms still remain unclear even after normalization 
of serum creatinine. Therefore, if we are considering the 
acute creatinine elevation as our primary target, just we 
are targeting an epiphenomenon. Even we can make an 
analogy between this condition and micro-albuminuria as 
the later predicts the target organ involvement in the future 
but not directly predispose to cardiovascular risks. Hence, 
contrast-associated acute kidney injury may predict future 
development toward chronic kidney disease (15). 
Authors’ contribution 
MAD prepared the first draft. MRA and MAMS revised 
the manuscript. All authors read and signed the final 
paper. 
Conflicts of interest 
The authors declared no competing interests. 
Ethical considerations 
Ethical issues including plagiarism, double publication, 
and redundancy have been completely observed by the 
authors. 
Funding/Support 
None.
References 
1. Mehran R, Aymong E D, Nikolsky E, Lasić Z, Iakovou 
I, P Fahy M, et al. A simple risk score for prediction 
of contrast-induced nephropathy after percutaneous 
coronary intervention: development and initial validation. 
J Am Coll Cardiol. 2004;44:1393-9. doi: 10.1016/j.
jacc.2004.06.068.
2. Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM, 
Hilton S, Reese PP. The controversy of contrast-induced 
nephropathy with intravenous contrast: what is the risk? 
Am J Kidney Dis. 2019. pii: 0272-6386(19)30844-3. doi: 
10.1053/j.ajkd.2019.05.022
3. Hu X, Zhuang XD, Li Y, Li FF, Guo Y, DU ZM, et al. 
A nomogram to predict contrast induced nephropathy in 
patients undergoing percutaneous coronary intervention: 
Is the “anti-aging” agent klotho a candidate predictor? Int 
Heart J. 2017;58:191-6. doi: 10.1536/ihj.16-213.
4. Bienholz A, Wilde B, Kribben A. From the nephrologist’s 
point of view: diversity of causes and clinical features of 
acute kidney injury. Clin Kidney J. 2015;8:405-14. doi: 
10.1093/ckj/sfv043.
5. Sato A, Hoshi T, Aonuma K. No prophylaxis is non-inferior 
and cost-saving to prophylactic intravenous hydration in 
preventing contrast-induced nephropathy on requiring 
iodinated contrast material administration. J Thorac Dis. 
2017;9:1440-2. doi: 10.21037/jtd.2017.05.59.
6. Liu Y, Liang X, Xin S, Liu J, Sun G, Chen S, et al. 
Risk factors for contrast-induced acute kidney injury 
(CI-AKI): protocol for systematic review and meta-
analysis. BMJ Open. 2019;9:e030048. doi: 10.1136/
bmjopen-2019-030048.
7. Balghith MA.The Effect of Contrast Administration on 
Renal Function after Cardiac Catheterization in Saudi 
Patients. Heart Views. 2019;20:83-86. doi: 10.4103/
HEARTVIEWS.HEARTVIEWS_69_19.
8. Gurm HS, Seth M, Kooiman J, Share D. A novel tool for 
reliable and accurate prediction of renal complications in 
patients undergoing percutaneous coronary intervention. 
J Am Coll Cardiol. 2013;61:2242-8.
9. Akyuz S, Karaca M, Kemaloglu Oz T, Altay S, Gungor 
B, Yaylak B, et al. Efficacy of oral hydration in the 
prevention of contrast-induced acute kidney injury 
in patients undergoing coronary angiography or 
intervention. Nephron Clin Pract. 2014;128:95–100. 
doi: 10.1159/000365090.
10. Do C. Intravenous contrast: friend or foe? a review on 
contrast-induced nephropathy. Adv Chronic Kidney Dis. 
2017;24:147-9. doi: 10.1053/j.ackd.2017.03.003.
11. Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass 
A, Thwin SS, et al. Outcomes after angiography with 
sodium bicarbonate and acetylcysteine. N Engl J Med. 
2018;378:603-614. doi: 10.1056/NEJMoa1710933. 
12. Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers 
BA, Janssen MM, Vermeeren MA, et al. Prophylactic 
hydration to protect renal function from intravascular 
iodinated contrast material in patients at high risk 
of contrast-induced nephropathy (AMACING): a 
 www.nephropathol.com                                                     Journal of  Nephropathology, Vol 8, No 4, October 2019  
                                 Contrast-associated kidney injury
3
prospective, randomised, phase 3, controlled, open-label, 
non-inferiority trial. Lancet. 2017;389:1312-22. doi: 
10.1016/S0140-6736(17)30057-0.
13. Mehran R, Dangas GD, Weisbord SD. Contrast-
Associated Acute Kidney Injury. N Engl J Med. 2019; 
380:2146-2155. doi: 10.1056/NEJMra1805256.
14. Liu K, Zhou LY, Li DY, Cheng WJ, Yin WJ, Hu C, et 
al. A novel rat model of contrast-induced nephropathy 
based on dehydration. J Pharmacol Sci. 2019. pii: 1347-
8613(19)35705-6. doi: 10.1016/j.jphs.2019.09.003.
15. Matsushita K, Coresh J, Sang Y,Chalmers J, Fox C, 
Guallar E, et al. Estimated glomerular filtration rate and 
albuminuria for prediction of cardiovascular outcomes: 
a collaborative meta-analysis of individual participant 
data.Lancet Diabetes Endocrinol. 2015;3:514-25. doi: 
10.1016/S2213-8587(15)00040-6.
Copyright © 2019 The Author(s); Published by Society of Diabetic Nephropathy Prevention. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted 
use, distribution, and reproduction in any medium, provided the original work is properly cited.
